Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
12/2003
12/11/2003US20030228982 Substituted phenyl derivatives
12/11/2003CA2487666A1 Anthelmintic and insecticidal thiophene derivatives
12/10/2003EP1369410A1 Process for the stereoselective reduction of derivatives of 4-aryl-4-oxobutyric acid
12/10/2003EP1369115A1 Methods of preventing breast cancer by the administration of Raloxifene
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368336A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
12/10/2003EP1368335A2 Novel amino dicarboxylic acid derivatives with pharmaceutical properties
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1222181B1 Method for preparing a benzofuran or benzothiophene compound
12/10/2003EP1200393B1 Oxime amides and hydrazone amides having fungicidal activity
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1461301A Benzo [b] thiophene derivative and process for producing the same
12/10/2003CN1460679A Synthesis method of medicine for curing senile dementia
12/10/2003CN1130360C Substituted thienocycloalk (en)ylamino-1,3,5-triazine
12/10/2003CN1130357C Process for synthesis of benzothiophenes
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/09/2003US6660868 Photochromic reaction occurs in crystalline state; useful in optical recording media, display panels, sensors, optical switch devices due to variation in color, refractive idex, and permeability with light irradiation/phase change
12/09/2003US6660769 The presence of a substituted amine functional group in the C-3 position of 2,2-dialkyl-1,4-butyrolactones leads to a greater enhancement in GABA effects
12/09/2003US6660764 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099276A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003086309A3 NF-κB INHIBITORS
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle
12/04/2003US20030225289 Optical isomers of tricyclic amino alcohol derivatives including 2-(N-(2-(9H-carbazol-2-yloxy)ethyl))amino-1-((3-methylsulfonylamino)- phenyl)ethanol; reduction of a 2-bromo-1-(3-nitrophenyl)ethanone, epoxidation; aminosulfonation
12/04/2003US20030225274 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates
12/04/2003US20030225266 N-aromatic or heteroaromatic-oxyalkylene, hydrocarbylnamide derivatives useful for potentiating glutamate receptor function; Alzheimer's Disease; antidepressants; cognition activators; psychosis; psychiatric and neurological disorders
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225154 Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differentail cns receptor activity and behavior
12/04/2003US20030225153 Process for preparing arylaminopropanols
12/04/2003US20030225140 Use of 2-amino-4-heteroarylethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/04/2003US20030225097 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225064 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224288 Stimulation sensitive composition and compound
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/03/2003EP1367111A1 Photochromic material
12/03/2003EP1366043A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
12/03/2003EP1366033A1 Chemical compounds
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366010A2 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
11/2003
11/27/2003WO2003097632A1 Propanolamine derivatives, process for preparation of 3-n-methylamino-1-(2-thienyl)-1-propanols and process for preparation of propanolamine derivatives
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097036A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003WO2002100388A3 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia
11/27/2003US20030220392 Prophylaxis of bacterial infections by administering 2'-(6-Chloropiperonyl)-3-(2,6-dichlorobenzyloxy)cinnamic acid and/or racemic mixtures, as antibiotics
11/27/2003US20030220390 Carbocyclic oxy amines such as 2-benzylidene-6-dimethylamino methylcyclohexanone, used as analgesics
11/27/2003US20030220389 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220340 Aryl and heteroaryl compounds as antibacterial and antifungal agents
11/27/2003US20030220326 Compounds, pharmaceutical compositions, and methods for inhibiting cyclin-dependent kinases
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors
11/27/2003US20030219664 Electrophotographic photoreceptor, and electrophotographic apparatus using the same
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2483286A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/26/2003EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363618A1 Pharmaceutical composition for treating multiple sclerosis
11/26/2003EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
11/26/2003EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same
11/26/2003CN1458928A N-substituted benzothiophenesulfonamide derivatives
11/26/2003CN1458143A Process for preparing N-aroyl-L-glutaminic acid
11/26/2003CN1128782C Catalyst for decarbonylation reaction
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 329